Brookstone Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
20,586
+4,844
+31% +$891K 0.04% 369
2026
Q1
$2.97M Buy
15,742
+291
+2% +$61.3K 0.03% 398
2025
Q4
$3.07M Sell
15,451
-681
-4% -$138K 0.04% 380
2025
Q3
$3.28M Buy
16,132
+3,278
+26% +$582K 0.04% 372
2025
Q2
$2.26M Sell
12,854
-1,428
-10% -$215K 0.03% 402
2025
Q1
$1.92M Buy
+14,282
New +$1.88M 0.03% 418
2022
Q1
Sell
-100
Closed -$7K 852
2021
Q4
$7K Buy
+100
New +$7.31K ﹤0.01% 747

Other funds holding THC

Brookstone Capital Management's THC Position: Q2 2026 in Review

Brookstone Capital Management increased its Tenet Healthcare (THC) stake by 31% in Q2 2026, buying an estimated $891K and bringing the position to 20,586 shares worth $3.85M. The position accounts for 0.04% of the portfolio, ranked #369.

Brookstone Capital Management first reported a position in THC in Q4 2021 and has held it in 7 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Brookstone Capital Management held 20,586 shares of Tenet Healthcare worth $3.85M as of Q2 2026.
  • Brookstone Capital Management bought 4,844 Tenet Healthcare shares in Q2 2026, an estimated $891K.
  • Tenet Healthcare made up 0.04% of Brookstone Capital Management's portfolio in Q2 2026, its #369 holding.
  • Brookstone Capital Management first reported a position in Tenet Healthcare in Q4 2021 and has held it in 7 quarters since.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.